Induced Pluripotent Stem Cell Market Is Expected to Witness a Strong CAGR of 7.0% During 2019-2025
Growing interest in personalizing regenerative medicines underlies the growing potential of induced pluripotent stem cell technology. Pharmaceutical industry in various parts of the world are keen on leveraging the potential of induced pluripotent stem cells engineering. A growing body of research on advancing the potential of embryonic stem cells in stem cell biology is catalyzing new avenues, especially in APEC.
View full press release